About Conference

    Dear Colleagues,

    Apex Global Meetings is delighted to announce and cordially invites all the participants across the globe to attend the 2nd Global Summit on Human Genetics and Genetical Disorders (GSHGGD2025), which will be taking place during September 11-13, 2025, Kuala Lumpur, Malaysia. 

    The theme would aim to Advancements in Genetical Engineering and Regenerative Medicine. Scientific Tracks designed for this conference will enable the attendees and participants to learn extremes.

    GSHGGD2025 aims to gather the renowned scientists, young and brilliant researchers, academicians, healthcare professionals, and business delegates, and exceptional student communities across the globe under one roof and organize a healthy discussion so that the researchers and authors can present their work at the conference.

    We would like to strongly encourage you to submit your abstracts and register to attend GSHGGD2025 in order to share your achievements in the fields of Genetics and genetic Disorders.

    We look forward to your valuable presence at GSHGGD2025 during September 11-13, 2025, in Kuala Lumpur, Malaysia.

    Regards,
    Divya P | Sr. Event Manager
    GSHGGD2025
    Apex Global Meetings | gshggd@apexglobalmeetings.com
    Ph.:+918977610040

    DNA (Deoxyribonucleic Acid): The molecule that carries genetic instructions used in the growth, development, functioning, and reproduction of all known living organisms.

    Gene: A segment of DNA that contains coding information for the synthesis of proteins, which determine traits in an organism.

    Chromosome: A thread-like structure composed of DNA and protein that contains genes; humans have 23 pairs of chromosomes.

    Genome: The complete set of genes or genetic material present in a cell or organism.

    Mutation: A change in the DNA sequence that can lead to variations in traits or cause genetic disorders.

    Genotype: The genetic constitution of an individual organism, often contrasted with phenotype.

    Phenotype: The observable physical or biochemical characteristics of an organism, as determined by both genetic makeup and environmental influences.

    Allele: One of two or more versions of a gene that are found at the same place on a chromosome.

    Dominant Trait: A genetic trait that is expressed in the phenotype even when only one copy of the gene is present.

    Recessive Trait: A genetic trait that is expressed only when two copies of the gene are present.

    Genetic Variation: Differences in DNA sequences among individuals within a population, leading to diversity in traits.

    Mendelian Inheritance: The pattern of inheritance that follows the laws formulated by Gregor Mendel, based on the segregation and independent assortment of genes.

    Genetic Engineering: The deliberate modification of the characteristics of an organism by manipulating its genetic material.

    CRISPR-Cas9: A powerful tool for editing genomes, allowing researchers to alter DNA sequences and modify gene function.

    Epigenetics: The study of changes in gene expression that do not involve alterations to the underlying DNA sequence.

    Genetic Disorder: A disease or condition caused by an abnormality in an individual's DNA.

    Heritability: The proportion of observed variation in a particular trait among individuals in a population that is due to genetic differences.

    Genetic Linkage: The tendency of genes located close together on a chromosome to be inherited together.

    Polygenic Traits: Traits that are controlled by multiple genes, often contributing to complex traits like height and skin color.

    Genome Sequencing: The process of determining the complete DNA sequence of an organism's genome at a single time.

    The Global Genetic Analysis The market was evaluated at USD 10.55 Billion In 2023 And Is Expected To Attain Around USD 23.60 Billion By 2033, Growing At A Cag Of 8.39% From 2024 To 2033. The Increasing Demand For Genetic Testing services Driving Growth Within The Genetic Analysis Market.

    The Genetic Analysis Market Is Experiencing Significant Transformation Due To Advances In Genetic Technology, Which Are Fundamentally Changing Perceptions And Practices Within The Healthcare Industry. At The Heart This Transformation Lies in the process of genetic analysis, Which Involves The Examination Of DNA Samples To Identify Mutations That May Influence Disease Susceptibility Or Treatment Response. This Analysis Is Pivotal For Understanding The Structure And Function Of Genes With Techniques Such As Gene Cloning Plays A Crucial Role In Isolating And Replicating Specific Genes For Detailed Examination.

    One Notable Aspect Of Genetic Analysis Is Its Diverse Clinical Applications. It Serves As A Diagnostic Tool, Aiding In The Confirmation Of Diagnoses In Symptomatic Individuals, While Also Facilitating The Monitoring Of Disease Prognosis And Treatment Response. Additionally, Genetic Analysis Enables Predictive Or Predisposition Testing, Allowing For identification Individuals At Risk Of Developing Certain Diseases Before Symptoms Manifest.

    The Emergence Of Predictive Genetic Testing Is Creating New Market Opportunities, As It Enables Proactive Disease Prevention Strategies And Early Interventions. As Perceptions Regarding Genetic Testing Continue To Evolve, The The market for genetic analysis is expected to witness sustained growth, Driven By Its Potential To Revolutionize Patient Care And Improve Health Outcomes.

    North America To Sustain Its Position In The Upcoming Years With The U.S. Being Largest Contributor

    In 2023, North America Emerged As The Dominant Force In The Genetic Analysis Market, Particularly In The United States. The Us Showcased A Robust Infrastructure: With 200 Laboratories Actively Conducting 37,124 Clinical Tests, Underscoring The Region's Significant Investment And Adoption Of Genetic Analysis Technologies. Notably, 29 Laboratories specialize In whole-exome Sequencing (Wes), While 17 Laboratories Focused On Whole Genome Sequencing (WGS), Indicating A Wide Array Of Genetic Testing Capabilities Available Within The Country.

    The United States Exhibits A Proactive Approach Towards healthcare. As Evidenced By Mandatory Newborn Screening Programs Targeting A Specific Set Of Genetic Diseases. Although The Exact Set Of Diseases Screened May Vary From State To State, The Emphasis Remains On Conditions Where Early Diagnosis Is Crucial For Effective Treatment Or Prevention Strategies. This Regulatory Framework Underscores The Importance Placed On Leveraging Genetic Analysis For Proactive Healthcare Management And Disease Prevention Initiatives.

    Beyond Clinical Applications: Genetic Analysis In North America Extends To Ecological And Environmental Contexts. The Presence Of Invasive Species Such As Phragmites Australis Subsp. Australis Poses Ecological Challenges Across Multiple Regions. The Co-Occurrence Of This Invasive Subspecies With Native Counterparts And Instances Of Hybridization That Necessitate Precise Differentiation Methods For Effective Management Strategies. Genetic Analysis Plays A Pivotal Role In Distinguishing Between Phragmites Subspecies Or Haplotypes, Facilitating Targeted Management Efforts To Mitigate Ecological Harm And Preserve Native Ecosystems.

    Important Dates


    Abstract Submission Deadline

    August 10, 2025

    Earlybird Registration Deadline

    November 05, 2024

    Standard Registration Deadline

    April 05, 2025

    Onspot Registration

    September 11, 2025

    Supporting Journal Collaborations

    Scientific Committee

    Volen Atim

    Dr. Raphael Mechoulam

    Hebrew University
    Israel
    Volen Atim

    Dr. Omid Akbarzadeh Pivehzhani

    University of Malaya
    Malaysia
    Volen Atim

    Dr. Magdalena Piekutowska

    Pomeranian University of Slupsk
    Poland
    Volen Atim

    Dr. Boniello Carmine

    University of Salerno
    Italy

    Registration

    Registration Includes

    • Access to all conference sessions, poster and exhibition area
    • Conference kit including name tag, program booklet and Abstracts book
    • 2 Coffee breaks and lunch for all the event days of the conference
    • Certificate of participation from Conference chair/ Session chair
    • Access to the all scientific sessions
    • Access to Business Development Sessions and Global Networking Session

    Benefits of Joining Conference

    • Encouraged to publish full length articles in Supporting Journals with discounted APC charges
    • Best Oral, Poster and Young Research Forum (YRF) presentation awards
    • Get Opportunity to Collaborate with future Apex Global Meetings
    • Avail Group Booking Discounts
    • All the articles presented in this conference will be considered for publications as per their quality in SCI / SCIE / SCOPUS / Peer Reviewed journals of Springer and / or other publishers

    Group Booking Discounts

    Groups of three or more will receive a Special discount by using the group code. If you have any queries, please contact us at or call

    gshggd@apexglobalmeetings.com